|
Volumn 45, Issue 8, 2000, Pages 1601-1607
|
Sequential group trial to determine gastrointestinal site of absorption and systemic exposure of azathioprine
a,b a,b a,b a,b a,b a,b a,b a,b |
Author keywords
6 mercaptopurine; Azathioprine; Bioavailabili ty; Gastrointestinal; Inflammatory bowel disease; Pharmacokinetics
|
Indexed keywords
AZATHIOPRINE;
MERCAPTOPURINE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EXPOSURE;
ENTERITIS;
GASTROINTESTINAL ABSORPTION;
HUMAN;
LEUKOPENIA;
MALE;
MEAN RESIDENCE TIME;
NORMAL HUMAN;
OPPORTUNISTIC INFECTION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
TISSUE DISTRIBUTION;
6-MERCAPTOPURINE;
ADOLESCENT;
ADULT;
AREA UNDER CURVE;
AZATHIOPRINE;
CECUM;
HUMANS;
INTESTINAL ABSORPTION;
JEJUNUM;
MALE;
MIDDLE AGED;
STOMACH;
|
EID: 0033831048
PISSN: 01632116
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1005573229786 Document Type: Article |
Times cited : (9)
|
References (30)
|